Hsp90 activator Aha1 drives production of pathological tau aggregates
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Significance: The accumulation of toxic tau protein, as in Alzheimer’s disease, is regulated by the 90-kDa heat shock protein (Hsp90) chaperone system. Inhibition of Hsp90 has been shown to reduce tau levels. However, Hsp90 inhibition can be problematic due to a lack of blood–brain barrier permeability and established toxicities. Here, we demonstrate that the Hsp90 cochaperone, ATPase homolog 1 (Aha1), dramatically increases the production of aggregated tau in vitro and in a mouse model of neurodegenerative disease. Moreover, inhibition of Aha1 reduced tau accumulation in cultured cells. These data identify Aha1 as a target for the treatment of tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 1×
“T microtubule-associated protein tau (MAPT, tau) accumulates and aggregates in a family of neurodegenerative diseases called tauopathies (1), with the most common being Alzheimer’s disease (AD) (2).”
BackgroundTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1×
“T microtubule-associated protein tau (MAPT, tau) accumulates and aggregates in a family of neurodegenerative diseases called tauopathies (1), with the most common being Alzheimer’s disease (AD) (2).”
BackgroundCaughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650 · cited 1×
“In particular, the pathogenic formation of oligomeric tau species is thought to be a major contributor to disease progression (3).”
BackgroundRamsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3279-05.2005 · Cited by 702 · cited 2×
“Samples were prepared as previously described (33) to obtain soluble (S1) and sarkosyl-insoluble (P3) fractions.”
MethodAccelerated neurodegeneration through chaperone-mediated oligomerization of tau
Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69003 · Cited by 322 · cited 3×
“Human tissue was stained as previously described using immunofluorescent secondary antibodies (17, 37).”
BackgroundMethodSelf-citationHsp90-Tau complex reveals molecular basis for specificity in chaperone action
Karagöz, G. E., Duarte, A. M. S., Akoury, E., Ippel, H., Biernat, J., Morán Luengo, T., Radli, M., Didenko, T., Nordhues, B. A., Veprintsev, D. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.037 · Cited by 318 · cited 1×
“Of the proteins regulated by Hsp90, often referred to as “clients,” tau is one of the most thoroughly characterized (6).”
BackgroundSelf-citationAlamed, J., Wilcock, D. M., Diamond, D. M., Gordon, M. N., & Morgan, D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.275 · Cited by 256 · cited 1×
“The RAWM task was performed as previously described (35).”
MethodSelective inhibitors of the FK506-binding protein 51 by induced fit
Gaali, S., Kirschner, A., Cuboni, S., Hartmann, J., Kozany, C., Balsevich, G., Namendorf, C., Fernandez-Vizarra, P., Sippel, C., Zannas, A. S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1699 · Cited by 245 · cited 2×
“This has led to the pursuit of Hsp90 cochaperones as distinct drug targets offering an alternative to Hsp90 (5, 12).”
BackgroundChadli, A., Felts, S. J., Wang, Q., Sullivan, W. P., Botuyan, M. V., Fauq, A., Ramirez-Alvarado, M., & Mer, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081018 · Cited by 94
The Mechanism of Hsp90 ATPase Stimulation by Aha1
Wolmarans, A., Lee, B., Spyracopoulos, L., & LaPointe, P. (2016) · Scientific Reports · doi:10.1038/srep33179 · Cited by 72
Research works printed but not linked: 28
- 10.1002/jnr.21417 · DOI · Paper page
- 10.1517/14728222.2014.943185 · DOI · Paper page
- 10.1146/annurev-pharmtox-010814-124332 · DOI · Paper page
- 10.1158/1078-0432.CCR-11-1000 · DOI · Paper page
- 10.2174/1568026616666160413141350 · DOI
- 10.1158/1541-7786.MCR-15-0234 · DOI · Paper page
- 10.1016/j.ctrv.2012.10.001 · DOI · Paper page
- 10.1038/nsmb.2502 · DOI
- 10.1074/jbc.M113.532523 · DOI
- 10.1016/j.cell.2006.09.043 · DOI · Paper page
- 10.1021/cb5008713 · DOI
- 10.1016/B978-0-12-394816-8.00001-5 · DOI
- 10.4161/onci.21173 · doi:10.4161/onci.21173
- 10.1016/j.bmc.2016.08.070 · DOI
- 10.1158/1535-7163.MCT-07-0484 · DOI · Paper page
- 10.1074/jbc.M112.427328 · DOI
- 10.1007/s10637-013-9987-y · DOI
- 10.1016/j.bcp.2009.09.017 · DOI · Paper page
- 10.3233/JAD-2012-121534 · DOI
- 10.1074/jbc.M409267200 · DOI · Paper page
- 10.1021/cb800162x · DOI · Paper page
- 10.1021/mp200346y · DOI
- 10.1177/2472555216688312 · DOI
- 10.1021/acsmedchemlett.6b00224 · DOI
- 10.1021/acs.jmedchem.5b01354 · DOI
- 10.2353/ajpath.2009.080764 · DOI
- 10.1523/JNEUROSCI.5397-12.2013 · DOI · Paper page
- 10.1016/0891-0618(94)90028-0 · DOI · Paper page
Cited by
Structure, Function, and Regulation of the Hsp90 Machinery
Biebl, M. M., & Buchner, J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034017 · Cited by 304
Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144
Wang, L., Bharti, Kumar, R., Pavlov, P. F., & Winblad, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112915 · Cited by 92
Lee, K., Thwin, A. C., Nadel, C. M., Tse, E., Gates, S. N., Gestwicki, J. E., & Southworth, D. R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.023 · Cited by 76
Metadata
- Authors
- Shelton, L. B., Baker, J. D., Zheng, D., Sullivan, L. E., Solanki, P. K., Webster, J. M., Sun, Z., Sabbagh, J. J., Nordhues, B. A., Koren, J., Ghosh, S., Blagg, B. S. J., Blair, L. J., & Dickey, C. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-08-21
- Volume
- 114
- Issue
- 36
- Pages
- 9707-9712
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2747080631
- Cited by
- 128
- References
- 10
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS073899)
- HHS | NIH | National Institute of Mental Health (MH103848)
- Health Services Research and Development (BX001637, BX002475)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hsp90 activator Aha1 drives production of pathological tau aggregates. https://app.cochat.ai/papers/10.1073/pnas.1707039114
- The paper
- Shelton, L. B., Baker, J. D., Zheng, D., Sullivan, L. E., Solanki, P. K., Webster, J. M., Sun, Z., Sabbagh, J. J., Nordhues, B. A., Koren, J., Ghosh, S., Blagg, B. S. J., Blair, L. J., & Dickey, C. A. (2017). Hsp90 activator Aha1 drives production of pathological tau aggregates. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1707039114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.